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The Carcinogenicity of Beryllium
by Marvin Kuschner*
Beryllium, some ofits alloys, and avariety ofits compounds have induced malignanttumors of
the lung and osteogenic sarcoma in experimental animals. Three animal species, monkeys,
rabbits, and rats, have been shown to be susceptible.
Beryllium induces morphological transformation in mammalian cells and enhances viral
transformation of mammalian cells. It has been shown to decrease fidelity of DNA synthesis.
It has been recognized that exposure to compounds of this metal will, in some individuals,
result in a chronic granulomatous disease of the lung. A series of overlapping recent human
epidemiological studies have been suggestive of an increase in the incidence of lung cancer in
populations occupationally exposed to beryllium. Such studies, together with animal and in vitro
studies, argue for the strong presumption of a carcinogenic hazard to man in occupational
beryllium exposures.
Recognition ofthe potential hazards of exposure
to compounds ofberyllium is offairly recent origin.
As late as 1943, Bulletin No. 181 of the United
States Public Health Service attributed lung dis-
ease in exposed workers toirritating anions such as
fluoride (1). German (2-5), Italian (6, 7) and Russian
(8, 9) reports of pulmonary disease following on
exposure to beryllium compounds had appeared in
the 30's and 40's and these were subsequently
amplified by descriptions of the disease clinically,
radiologically and pathologically in the United States.
In 1946 Hardy and Tabershaw described the
occurrence of"delayed chemical pneumonitis" in 17
workers in a plant manufacturing fluorescent tubes
(10). This landmark paper clearly established the
clinicalandmorphologicalcharacteristicsofberylliosis.
The lack of relationship between the incidence of
the disease and the level ofexposure represented a
puzzling feature ofberylliosis. In 1951, Sterner and
Eisenbud proposed hypersensitivity toberyllium as
a mechanism for the granulomatous pulmonary
disease and for the lesions evoked by accidental
implantation of beryllium in the skin (11). The
demonstration by Belman that beryllium combines
with proteins in the skin provided a model for
understanding the production of a metalloprotein
complex that might serve as an antigen in the
induction of hypersensitivity (12).
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The position of the U.S. Public Health Service
was revised with the publication in 1972 of Public
Health Service Publication #2173, (13). In addition
to summarizing the then-available data on the
nature of the disease and recommending environ-
mental limits of exposure and methods of control,
the bulletin reviewed the uses ofberyllium and the
potential sources of industrial exposure. The pros-
pects for human occupational encounter with beryl-
lium are summarized by Fishbein as are the sources
and levels of general environmental contamination
by the metal (14). This summary emphasizes, as do
those coming from the EPA (15, 16), the major
contribution to atmospheric pollution made by burn-
ing coal and oil. The recommended permissible
concentrations have been set at an in-plant concen-
tration not exceeding 2 ,ug/m3 as an average overan
eight-hour day; no exposure greater than 25 ,ug/m3
for any period oftime, however short; plant neigh-
borhood exposures not exceeding average monthly
concentrations of 0.01 ,ug/m3.
In 1946, Gardner and Heslington in a brief note
reported, in apparent astonishment, the first in-
stance of a tumor experimentally induced by the
administration of beryllium (17). Seven rabbits
surviving injection of zinc beryllium silicate for
seven or more months all developed osteosarcomas
at multiple sites. This observation has been fol-
lowed by ample confirmation of the ability of
beryllium to induce malignant tumors in monkeys,
rabbits, and rats. Beryllium's carcinogenic activity
has been demonstrated when in the form of the
101metal, some of its alloys, and a variety of com-
pounds. Ithasproduced lungcancers and osteogenic
sarcoma. The lung cancers result from pulmonary
instillation or inhalation with consequent direct
action on the lung and the bone tumors reflect
beryllium's bone seeking propensities (18). Experi-
mental approaches to beryllium carcinogenesis are
summarized in Table 1.
It should be noted that the levels of exposure
producing tumors of the lung on inhalation in rats
and monkeys was 30-40 ,ug/m3.
In in vitro tests of genotoxic properties, beryl-
lium has been negative as a mutagen in bacterial
systems (46, 47). However, beryllium has been
shown to induce morphological transformation in
mammalian cells and to enhance viral transfonna-
tion of mammalian cells (48, 49). The testing of
metals in in vitro assay is reviewed by Sirover (50)
in this symposium. Beryllium's ability to decrease
the fidelity of DNA synthesis is reviewed in this
symposium by Loeb and Zakour (51).
Epidemiological evidence for an increased risk of
cancer in humans occupationally exposed to beryl-
liumispresentlyuncertain. Fourreports appearing
between 1967 and 1970 failed to show evidence of
carcinogenicity for humans (52-55). Four more
recent studies of the same populations all show
what appears to be an excess of lung cancer in
individuals (white males) exposed to beryllium in
the courses of employment (57-59). These studies
have been criticized on the following grounds:
comparison with lung cancer rates for all U.S.
white males may not be appropriate; the straight-
line extrapolation of lung cancer death rates from
Table 1. Carcinogenicity of beryllium compounds.a
Route of
Year Species Compound administration Tumor Reference
1946 Rabbit
1949 Mouse
1949 Rabbit
1950 Rabbit
1950 Rabbit
1950 Rabbit
1951 Rabbit
1953 Rat
1954 Rabbit
1954 Rabbit
1957 Rat
1961 Rabbit
1964 Rabbit
1964 Rabbit
1965 Rat
1966 Monkey
Monkey
1967 Rat
1968 Rabbit
1969 Rat
1969 Hamster
1969 Monkey
1969 Rabbit
1972 Rat
1975 Rat
1975 Rabbit
Zinc berylium silicate
Zinc beryllium silicate
Zinc beryllium silicate
Zinc beryllium silicate
and beryllium metal
Zinc beryllium silicate
Beryllium oxide and
zinc beryllium silicate
Beryllium oxide
Beryllium sulfate tetrahydrate
Beryllium phosphate,
beryllium oxide
Zinc beryllium silicate
Beryllium sulfate tetrahydrate
Zinc beryllium silicate
Zinc beryllium silicate
Zinc beryllium silicate
Beryllium sulfate tetrahydrate
Beryllium oxide
Beryllium sulfate tetrahydrate
Beryllium sulfate tetrahydrate
Beryllium oxide
Beryl ore, bertrandite ore
Beryl ore, bertrandite ore
Beryl ore, bertrandite ore
Zinc beryllium silicate,
beryllium silicate, beryllium oxide
Beryl ore, beryllium oxide
beryllium hydroxide,
beryllium metal
Beryllium fluoride,
beryllium chloride
Zinc beryllium silicate
beryllium chloride
Intravenous
Intravenous
Intravenous
Intravenous
Intravenous
Intravenous
Inhalation
Inhalation
Inhalation
Intravenous
Inhalation
Intravenous
Intravenous
Intravenous
Ingestion
Intratracheal
Instillation
Inhalation
Inhalation
Intravenous
Inhalation
Inhalation
Inhalation
Subperiosteal
injection
Intratracheal
Inhalation
Intramedullary
Osteosarcoma
"Malignant bone tumors"
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Lung cancer
(adeno and squamous)
Osteosarcoma
Osteosarcoma
Lung cancer
(adeno and squamous)
Osteosarcoma
Chondrosarcoma
Osteosarcoma
no greater than controls
Pulmonary cancer
(anaplastic)
Pulmonary cancer
Lung cancer
(alveolar-adeno Ca)
Osteosarcoma
Lung cancer (adeno)
no tumors
None
None
Osteosarcoma
"Pulmonary tumors"
Lung cancer
(adeno and squamous)
Osteosarcoma
(adeno and squamous)
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(17)
(19)
(19)
(22-24)
(21)
(20)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(34)
(35)
(36)
(37)
(37)
(37)
(38, 39)
(40)
(41)
(42)
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Route of
Year Species Compound administration Tumor Reference
1977 Rat Beryllium sulfate tetrahydrate Ingestion (43)
No greater than
controls
1978 Rat Beryllium oxide Inhalation Single lung cancer (44)
(adeno)
1979 Rat Beryllium metal, beryllium alloy, Intratracheal Lung cancer (adeno (45)
passivated beryllium metal, instillation and squamous)
beryllium hydroxide t
one examines the group in which more than 15
years had elapsed since the onset of employment.
Finally it should be recognized that shortperiods of
exposure toatoxicant do notrule out acausal effect
between that exposure and tumorinduction. This is
particularly true when the material in question is
durable and may remain for many years, and, in
addition, produces apotent competingnonneoplastic
disease. One is reminded of the emergence of
mesothelioma as a problem in asbestos exposure
after severe asbestosis disappeared and the inci-
dence oflungcancerdiminished with lowerlevels of
exposure.
The occurrence of a specific cell type of lung
cancer in association with occupational exposure
might be considered presumptive evidence of a
causal relationship. An attempt to examine this
the period of 1965-1967 to the later years under
study (1968-1975) ignores the increase in death
rates from this disease; the short period of expo-
sure for many of the lung cancer patients (the
majority in Wagoner's study were employed for
less than 12 months) presents the curious phenom-
enon ofcancer mortality being inversely related to
length of exposure; no account can be taken or
smoking habits which surely affect the outcomes of
comparisons where the excess risk is 1.4 times that
of the control population.
These objections are countered by the following
elements in the studies in question: Mancuso's 1980
study (58) compares mortality in the beryllium-
exposed workers originally studied in 1979 (56) to a
group of workers in the viscose rayon industry
rather than to national mortality rates and an
excess incidence of lung cancer still holds; the
borderline or nonexistent significance ofthe excess
in Wagoner's study (57), particularly if one substi-
tutes a more correct and higher figure for the
expected incidence, becomes more impressive if
possibility is inconclusive (60). In Wagoner's 47
cases of lung cancer deaths in beryllium workers,
27 samples of tissue were availble. One proved to
be a metastatic pancreatic carcinoma and another
an adenocarcinoma of uncertain primary site. Al-
though there was a deficit ofepidermoid cancers in
this group, the authors point out that there is no
reason to expect that the same distribution would
have held in the 20 cases for which specimens were
not received. Indeed, five of seven cases in which
cell types are recorded but in which no material
could be examined are epidermoid.
At the present time, a material which produces
malignant tumors in three animal species at differ-
ent sites and for which human epidemiological
studies are, at the very least, strongly suggestive
of a carcinogenic effect in man, must certainly be
regarded with a high degree ofsuspicion as being a
human carcinogen.
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